ArticleCNS neuroscience & therapeutics2023

Ofatumumab for the treatment of refractory anti-LGI1 encephalitis with long-term poor blood glucose control in type 1 diabetes.

Kaili Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.